Abstract
In the medical field, bone abnormality detection is a very important issue. Bone abnormalities include various diseases such as fractures, osteoporosis, bone tumors, and joint diseases. If these diseases are not diagnosed and treated in a timely manner, they can seriously affect the health and quality of life of patients. Artificial intelligence has made remarkable advances in Cluster analysis of medical big data, effectively mining its hidden associations to provide effective information for clinical diagnosis and medical research. However, the effectiveness of deep learning in domains with limited or no labeled data is often limited. To address this issue, we propose a novel and reliable two-stage unsupervised deep clustering framework for skeletal anomaly detection. This framework combines neural network parameters with feature clustering for collaborative learning to detect anomalies. We trained eight separate models, one for classification and seven for anomaly detection, using the MURA dataset, the largest publicly available skeletal imaging dataset. In the first stage, our approach achieved an average sensitivity and specificity of 99.76% and 99.53%, respectively. The second stage performed optimally with an average sensitivity and specificity of 83.28% and 97.56%, respectively. Our method can be easily implemented as software modules and used as a visualization tool for skeletal physicians, making it a promising approach for future development.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The authors received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval consent form. This study uses a public database and does not involve ethical issues
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Guola Zhou: Writing - Original Draft and Investigation
Caiping Hu: Conceptualization and Writing - Review & Editing
Yulin Zhang: Formal analysis and Data Curation
Jieru Jiang: Validation and Project administration
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
